Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.5K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer.

Therapeutic advances in medical oncology·2024
Same author

Effects of vegetation restoration on soil aggregate characteristics and soil erodibility at gully head in Loess hilly and gully region.

Scientific reports·2024
Same author

Predicting Preoperative Risk and Prognosis in Patients with Proliferative Hepatocellular Carcinoma.

Academic radiology·2024
Same author

Similar pipeline experiment and disaster control emergency plan of updraft airflow fire in mine.

Scientific reports·2024
Same author

Effect of AM fungi on the growth and powdery mildew development of Astragalus sinicus L. under water stress.

Plant physiology and biochemistry : PPB·2024
Same author

Fumarate Hydratase-Deficient Renal Cell Carcinoma With Paraganglioma Detected on 18 F-FDG PET/CT.

Clinical nuclear medicine·2024
Same journal

An accessible, absorbance-based plate reader assay to assess cumulative exposure of blood plasma & serum to thawed conditions.

Methods (San Diego, Calif.)·2026
Same journal

EC-isHCR: A rapid method for in situ hybridization chain reaction in diverse animal samples.

Methods (San Diego, Calif.)·2026
Same journal

Single-Molecule methods to investigate mechanisms of transcription by RNA polymerase of Mycobacterium tuberculosis.

Methods (San Diego, Calif.)·2026
Same journal

Detection and sequencing of Usutu virus during mosquito surveillance: Use of multiple assays and techniques for identification at low levels.

Methods (San Diego, Calif.)·2026
Same journal

Experimental validation of an AI-driven digital healthcare platform for oral health behavior and plaque assessment among vietnamese children.

Methods (San Diego, Calif.)·2026
Same journal

Zeta potential: An efficient and cost-effective alternative for investigating cell-surface interactions.

Methods (San Diego, Calif.)·2026
See all related articles

Related Experiment Video

Updated: Dec 16, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

GCN-BMP: Investigating graph representation learning for DDI prediction task.

Xin Chen1, Xien Liu1, Ji Wu2

  • 1Department of Electronic Engineering, Tsinghua University, Beijing 100084, China.

Methods (San Diego, Calif.)
|July 6, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces GCN-BMP, a novel graph convolutional network method for predicting drug-drug interactions (DDIs). GCN-BMP improves prediction accuracy by using end-to-end graph representation learning, offering better insights into vital molecular features.

Keywords:
DDIGraph representation learningInterpretabilityRobustnessScalability

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 16, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Artificial Intelligence

Background:

  • Concurrent drug administration can lead to unpredictable drug-drug interactions (DDIs), altering pharmacological activity.
  • Existing machine learning methods for DDI prediction often rely on drug features, potentially introducing noisy inductive bias.

Purpose of the Study:

  • To develop a novel and accurate method for predicting drug-drug interactions (DDIs).
  • To leverage end-to-end graph representation learning to overcome limitations of feature-dependent DDI prediction models.

Main Methods:

  • Introduced GCN-BMP (Graph Convolutional Network with Bond-aware Message Propagation), a new DDI prediction model.
  • Utilized end-to-end graph representation learning for DDI prediction.
  • Incorporated a self-contained attention mechanism for interpretability.

Main Results:

  • GCN-BMP achieved superior performance compared to baseline approaches on two real-world datasets.
  • The model demonstrated higher accuracy in predicting DDIs.
  • The attention mechanism identified key local atoms relevant to DDIs, aligning with domain knowledge.

Conclusions:

  • GCN-BMP offers an effective and interpretable approach for DDI prediction.
  • End-to-end graph representation learning is a promising direction for improving DDI prediction accuracy.
  • The method provides insights into the molecular basis of drug-drug interactions.